Financial Results quarter ended 30th June 2025.
The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2025.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Board Meeting Outcome for Outcome Of The Board Meeting
- Transgene Biotek Limited. Press Release Jul 30 2025
- Board Meeting Intimation for This Is To Inform You That A Meeting Of Board Of Directors Will Be Held On Thursday 07Th August 2025, In Order To Transact Following Businesses.
- Transgene Biotek Limited. Press Release Jul 25 2025
- Compliance-57 (5): intimation after the end of quarter
Later from Transgene Biotek
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Transgene Biotek Limited. Press Release Aug 13 2025
- Subject: Intimation About The Initiation Of Insolvency Process.This Is To Inform About The Receipt Of Intimation Today From M/S Babaji Nethralayya Private Limited Initiating An Action Under Section 7 Of The Insolvency And Bankruptcy Code, 2016, Read
- Transgene Biotek Limited. Press Release Sep 01 2025
- Intimation Extension Of Time For Holding Annual General Meeting Of The Company For The Financial Year Ended On March 31, 2025.
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek